Testing effectiveness (Phase 2)WithdrawnNCT02287727
What this trial is testing
Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment
Who this might be right for
Rectal AdenocarcinomaStage IIA Rectal CancerStage IIB Rectal Cancer+3 more
Roswell Park Cancer Institute